Serum Institute Of India (SII)

Malaria and other mosquito-borne diseases continue to plague the developing world (Representative Photo)

WHO Approves 2nd Malaria Vaccine Developed By Oxford University And Serum Institute Of India

BY Outlook Web Desk

?Representational Image

?DCGI Approves Market Authorisation For SII's Covid Vaccine Covovax As Heterologous Booster Dose

BY PTI

Worlds first nasal Covid-19 vaccine gets DCGA nod

SII Stopped Covishield Production In Dec 2021, Says Poonawalla; Claims There Are No Takers For Booster Shots As People Are Fed Up

BY PTI

The NTGAI Recommends Vaccination Against Cervical Cancer And Typhoid

The NTGAI Recommends Vaccination Against Cervical Cancer And Typhoid

BY PTI

<li id="bww17"><dl id="bww17"><sup id="bww17"></sup></dl></li>